Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Erythromycin, singles or in combination with other antibiotics not for veterinary use
Medicaments containing antibiotics, except penicillins and streptomycins, in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
W - Rating variable
Z - No special type of cargo code applicable
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $249.89 to $416.48.. | |
Does NSN 6505-00-080-0653 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Department Of The Army, Department Of The Air Force, U.s. Marine Corps, Department Of The Navy, National Institutes Of Health, and Kuwait | |
What is the NIIN of NSN 6505-00-080-0653? | |
000800653 or 00-080-0653 | |
Does NSN 6505-00-080-0653 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6505-00-080-0653? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Feb 27, 1972 |
Ld50 lc50 mixture: oral ld50 (rat) is >10g/kg
routes of entry: inhalation: yes skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: allergic skin and respiratory
reactions have been reported from erythromycin.
explanation of carcinogenicity: there are no ingredients above 0.1%
which are identified as carcinogens by ntp,iarc or osha.
effects of overexposure: skin: dermatitis.Inhal: asthma-like symptoms.
medical cond aggravated by exposure: persons with pre-existing
hypersensitivity to erythromycin may be at increased risk from
exposure.
First aid: skin: remove contaminated clothing;wash with soap and
water.Eyes: flush with water for 15 minutes.Inhal: remove to fresh
air.Give oxygen or artificial respiration if needed.Ingest: do not
induce vomiting. Get prompt qualified medical attention.
Hcc: n1
solubility in water: nil
appearance and odor: crystals.Odor and color not reported.
percent volatiles by volume: nil
Stability indicator/materials to avoid: yes
none specified by manufacturer.
stability condition to avoid: none specified by manufacturer.
hazardous decomposition products: none specified by manufacturer.
Waste disposal methods: dispose of in accordance with federal,state and
local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: erythromycin ethylsuccinate
cas: 1264-62-6
rtecs #: wm9800000
other rec limits: 0.1 mg/m3